Gilles Salles explains why you should join the virtual Lymphoma Hub Satellite Symposium

The Lymphoma Hub will hold a virtual satellite symposium at the European Society of Hematology (ESH) 2nd How to Diagnose and Treat: Lymphoma conference, on November 8, 2020, at 3:50 P.M. (CET). The Lymphoma Hub Chair, Gilles Salles, Memorial Sloan Kettering Cancer Center, New York, US, explains why you should join the virtual Lymphoma Hub Satellite Symposium.

While frontline treatment approaches in non-Hodgkin lymphomas and CLL have made tremendous progress, the treatment of patients with relapsed/refractory disease can be a challenge. During the Lymphoma Hub satellite symposium , five international experts, Gilles Salles,Marie-José Kersten ,  Kieron Dunleavy ,  Francesc Bosch , and  Astrid Pavlovsky willprovide an overview of the latest advances in the field, special treatment challenges, and regional differencesin approaching treatment decisions for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic lymphoma (CLL).